GE Healthcare Launches New Software to Expand Biacore T200’s Capabilities for Highly Sensitive, Focused Screening

12 Jun 2013
Share
Biacore™* T200 Software v.2.0 enhances the capabilities of Biacore T200, offering researchers a flexible and powerful tool for efficient processing of molecular interaction data. Together, they facilitate label-free screening of low molecular weight compounds and low abundance proteins, giving detailed binding profiles on molecule-drug candidate mechanisms of action that ultimately assist in earlier lead selection and optimization.

The new software simplifies and speeds up the generation and transformation of raw label-free interaction data into high-quality information, reducing the time needed for screening and hit validation. Versatile, easy-to-use wizards guide assay set up, and options are available for designing custom assays, making Biacore T200 ideal for a multi-user environment.

The new software encompasses algorithms for efficient ranking and qualification of binders versus non-binders, and enables comparison of datasets through normalization of sample responses by a number of means. By performing detailed evaluation of a single sample or co-evaluating up to 5000 single-concentration samples from multiple runs with the same ease, Biacore™ T200 Software v.2.0 significantly reduces the time required for evaluation of large lead series.

Request Info


Company website

GE Healthcare